Clinical outcomes in a cohort of patients with cutaneous T-cell lymphoma and COVID-19
Saved in:
Main Authors: | John S. Runge, PhD (Author), Redina Bardhi, BS (Author), Yang Xia, BS (Author), Neil K. Jairath, MD (Author), Ryan A. Wilcox, MD, PhD (Author), Lam C. Tsoi, PhD (Author), Trilokraj Tejasvi, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distinguishing reactive inflammatory dermatoses from lymphoma: 2 cases of severe drug reactions to phenytoin/phenobarbital and rosuvastatin mimicking lymphoma
by: Taylor Novice, BS, et al.
Published: (2020) -
Primary cutaneous lymphoma in a patient with mastocytosis: Is there an association?
by: Colin M. Kincaid, BS, et al.
Published: (2023) -
Adult-onset hydroa vacciniforme-like lymphoma in a long-term resident of the United States
by: Kenneth K. Yu, MD, PhD, et al.
Published: (2018) -
Reply to Correspondence to "Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator"
by: Rosanne Ottevanger, MD, et al.
Published: (2023) -
Itch in patients with cutaneous T-cell lymphoma as a quality of life indicatorCapsule Summary
by: Rosanne Ottevanger, MD, et al.
Published: (2022)